Choroidal Thickness Change in Response to Physiological and Refractive Changes
NCT ID: NCT03906279
Last Updated: 2022-03-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
250 participants
OBSERVATIONAL
2019-04-10
2026-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Objective Choroidal Thickness Measurements in Uveitis
NCT03889860
Measuring Choroidal Thickness Using Optical Coherence Tomography
NCT06272851
Three-dimensional Choroidal Vascularity Index in Common Fundus Diseases
NCT04790084
Retinal Thickness Analysis Using Optical Coherence Tomography
NCT00797134
Comparation of Different Devices to Measure Corneal Thickness
NCT01251705
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CROSSOVER
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Myopic participants
No interventions assigned to this group
Emmetropic participants
No interventions assigned to this group
Hyperopic participants
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* willing and able to understand and sign an informed consent form
Exclusion Criteria
* any disease that causes visual opacity of optic media that unable to perform OCT scanning
* current enrolment in another clinical trial/research project
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Wroclaw Medical University
OTHER
Wrocław University of Science and Technology
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Joanna Przeździecka-Dołyk, PhD
Role: PRINCIPAL_INVESTIGATOR
Wrocław University of Science and Technology
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Optics and Photonics
Wroclaw, , Poland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ST002.2018
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.